Skip to content

Fluorescent protein-based detection of metabolites in clinical specimens

Fluorescent protein-based detection of metabolites in clinical specimens

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023572
Enrollment
Unknown
Registered
2019-06-02
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous system disease/sudden deafness/suppurative otitis media

Interventions

control group:no intervention

Sponsors

600 Yishan Road, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients who underwent lumbar puncture and cerebrospinal fluid examination; (2) blood biochemical examination for clinical inpatients/outpatients; (3) inpatient/out-patient urine biochemical examination.

Exclusion criteria

Exclusion criteria: (1) suspected cranial hypertension and cerebral hernia; (2) suspected intracranial space-occupying lesions; (3) shock and other critical patients; (4) patients with severe coagulation dysfunction, such as hemophiliacs, are excluded.

Design outcomes

Primary

MeasureTime frame
unconjugated bilirubin;metabolite;

Countries

China

Contacts

Public ContactHaibo Shi

Shanghai Jiaotong University Affiliated Sixth People's Hospital

haibo99@hotmail.com+86 021-24058706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026